Article content and detailed guides remain in English. The selected language applies to controls and quick instructions.

Back to articles

Use cases

Email Prospecting Strategies for the Pharmaceutical Industry

By Email ExtractorPublished 8 min read
On this page

The Pharmaceutical Industry Landscape

The pharmaceutical industry includes drug discovery, development, manufacturing, distribution and commercialisation. Selling into pharma requires understanding the complex web of companies, regulations and decision-making processes:

Segment Key players Decision makers
Big Pharma Large multinational drug companies (Pfizer, Roche, Novartis, J&J) Procurement, R&D, commercial, medical affairs
Biotech Smaller drug development companies, often pre-revenue CEO, CSO, VP R&D, business development
CROs (Contract Research Organisations) Companies conducting clinical trials on behalf of pharma Business development, project management, scientific leads
CDMOs (Contract Development and Manufacturing) Companies manufacturing drugs on behalf of pharma Business development, quality, operations
Medical devices Companies making diagnostics, instruments, implants R&D, regulatory, procurement, marketing
Generics and biosimilars Companies making off-patent drugs Regulatory, business development, manufacturing
Specialty pharmacy Pharmacies handling complex, high-cost medications Pharmacy director, clinical pharmacist, operations
Distributors and wholesalers Companies distributing drugs to pharmacies and hospitals Procurement, category management, logistics
Pharma technology Software for clinical trials, regulatory, manufacturing CTO, IT director, VP operations
Animal health Veterinary pharmaceutical companies R&D, marketing, business development

Finding Pharmaceutical Industry Contacts

Drug company contacts

Source What you find How to access
FDA databases (NDAs, ANDAs, BLAs) Companies with approved drugs; regulatory contacts fda.gov
ClinicalTrials.gov Companies running clinical trials; principal investigators clinicaltrials.gov
SEC filings (10-K, proxy statements) Officer names, subsidiary lists, strategic plans sec.gov/edgar
Patent databases (USPTO, EPO) Inventors and assignees at pharma companies uspto.gov, epo.org
Industry conferences (BIO, CPHI, DIA, ASCO) Exhibitors, speakers, sponsors Conference websites
Pharma trade publications Company profiles, executive interviews Fierce Pharma, Endpoints News, STAT
State pharmacy board databases Licensed establishments State pharmacy board websites
DEA registrations Manufacturers handling controlled substances deadiversion.usdoj.gov
WHO prequalification Manufacturers with WHO-prequalified products who.int

Download conference exhibitor lists, FDA database exports or industry directories. Upload to Email Extractor to extract email addresses from PDF, HTML, CSV or XML files.

CRO and CDMO contacts

Source What you find How to access
ACRO (Association of Clinical Research Organizations) CRO member directory acrohealth.org
ISPE (International Society for Pharmaceutical Engineering) Pharma manufacturing professionals ispe.org
PDA (Parenteral Drug Association) Pharma manufacturing and quality professionals pda.org
Pharma Manufacturing magazine CDMO profiles and directory pharmamanufacturing.com
ClinicalTrials.gov sponsor data CROs managing trials clinicaltrials.gov
CPHI exhibitor lists Manufacturing and service companies cphi.com
Outsourced Pharma CDMO and CRO directory outsourcedpharma.com

Biotech and startup contacts

Source What you find How to access
BIO (Biotechnology Innovation Organization) Biotech company directory bio.org
Crunchbase Biotech funding data, founders, investors crunchbase.com
State biotech associations Local biotech company directories State association websites
NIH Reporter Companies receiving NIH grants (SBIR/STTR) reporter.nih.gov
Biotech incubators and accelerators Early-stage companies and their leadership Incubator/accelerator websites
Patent filings Biotech inventors and assignees USPTO, EPO
Scientific publications Researchers at biotech companies PubMed, Google Scholar

Email Patterns in Pharma

Company type Common patterns Notes
Big Pharma firstname.lastname@company.com Standard corporate; strict email security
Biotech first@company.com or first.last@company.com Smaller companies may use simpler patterns
CROs firstname.lastname@company.com Corporate pattern; global companies may have regional domains
CDMOs first.last@company.com Corporate pattern
Academic/research firstname.lastname@university.edu University email for academic collaborators
Government (FDA, EMA, etc.) firstname.lastname@fda.hhs.gov Government domains; do not cold email regulators about products
Hospitals and health systems first.last@hospital.org Often complex domains with regional variations

Pharma-specific email challenges

Challenge Why it happens Workaround
Strict email filtering Pharma companies have aggressive spam filters due to compliance requirements Use clean sending infrastructure; avoid spam trigger words
Compliance gatekeeping Regulated interactions mean some contacts cannot receive unsolicited vendor emails Target business-side contacts (procurement, IT, operations) rather than medical/scientific unless appropriate
Multiple email domains Large pharma companies have dozens of subsidiaries with different domains Research the corporate structure to find the right domain
Generic addresses Many pharma companies route enquiries through info@ or procurement@ portals Find individual contacts via LinkedIn or conference speaker lists
Anti-kickback regulations US Anti-Kickback Statute and similar laws restrict what you can offer to healthcare contacts Ensure outreach does not offer anything of value that could be construed as a kickback

Outreach Strategies by Segment

Big Pharma

Who to target What to offer Outreach approach
Procurement Cost savings, vendor consolidation, supply chain solutions Reference specific procurement categories; follow vendor registration processes
R&D / scientific Research tools, laboratory equipment, data analytics Reference specific therapeutic areas or technology platforms
IT / digital Software, digital transformation, data management Reference their digital strategy or technology challenges
Commercial / marketing Marketing services, market access, patient engagement Reference specific brands or therapeutic areas
Quality / regulatory Compliance tools, quality management, regulatory intelligence Reference specific regulations or audit findings
Manufacturing / supply chain Equipment, raw materials, packaging, logistics Reference capacity constraints or supply chain initiatives

Important: Vendor portals. Many large pharma companies require suppliers to register on vendor portals (Ariba, Coupa, Jaggaer) before engaging. Cold email may open a conversation, but the commercial process often runs through formal procurement channels.

Biotech startups

Who to target What to offer Outreach approach
CEO / founder Strategic services, platform partnerships Reference their pipeline, recent funding or scientific publications
CSO / VP R&D Research tools, CRO services, technology Reference their specific therapeutic area or technology platform
VP Business Development Licensing, partnerships, collaboration Reference pipeline assets or strategic gaps
CFO / VP Finance Financial services, insurance, accounting Reference funding stage and financial milestones
VP Operations Manufacturing, supply chain, facilities Reference scale-up challenges related to their development stage

Timing for biotech outreach:

Trigger event Outreach opportunity
Funding round announced Company has budget; likely hiring and building infrastructure
Clinical trial initiated Needs CRO, CMC, regulatory, patient recruitment services
FDA breakthrough designation Accelerated timeline; needs to scale operations quickly
Key hire announced New executive may bring new vendor relationships
Pipeline advancement (phase transition) New requirements at each development stage
Patent filing Validates technology; may signal commercialisation intent
Partnership or licensing deal Changed scope; new requirements

CROs and CDMOs

Who to target What to offer Outreach approach
Business development Technology, staffing, subcontracting Reference their service offerings and how you complement them
Project management Project management tools, communication platforms Reference common project management pain points
Quality assurance Quality systems, auditing, training Reference regulatory requirements (FDA, EMA, ICH)
IT Laboratory systems (LIMS), data management, security Reference their specific technology environment
Operations Equipment, consumables, facility management Reference capacity utilisation or expansion plans

Regulatory Considerations for Pharma Outreach

Regulation Impact on outreach
Anti-Kickback Statute (US) Cannot offer items of value to induce referrals; avoid offering gifts, free services or entertainment to HCPs
Sunshine Act (US) Transfers of value to physicians must be reported; track any value provided during the sales process
GDPR (EU) Standard data protection requirements; some pharma contacts are healthcare professionals with additional protections
PhRMA Code Industry voluntary guidelines for interactions with healthcare professionals
ABPI Code (UK) UK pharmaceutical industry code governing interactions with HCPs
IFPMA Code International federation code for pharmaceutical manufacturers
FDA promotional regulations Marketing of drugs and devices is regulated; ensure outreach does not make promotional claims outside approved labelling

Safe vs restricted outreach targets

Target type Outreach status Notes
Procurement professionals Generally safe Standard business outreach for goods and services
IT and operations staff Generally safe Standard business outreach for technology and services
Business development Generally safe Standard business outreach for partnerships
Commercial/marketing Exercise caution Marketing of drugs is regulated; ensure compliance
Medical affairs Exercise caution Interactions with medical affairs may be governed by industry codes
Healthcare professionals (HCPs) Restricted Subject to anti-kickback, Sunshine Act and industry codes
Government regulators (FDA, EMA) Do not cold email Interact through formal channels only

List Management for Pharma

List quality considerations

Factor Recommendation
Job change rate Pharma has moderate turnover; re-verify every 3-6 months
Company changes (M&A) Pharma has frequent M&A; monitor for company name changes and domain migrations
Role changes Scientists may move between companies; titles change with promotions
Compliance tracking Track all outreach to pharma contacts for compliance purposes
Suppression lists Maintain robust suppression lists; healthcare contacts may have do-not-contact preferences
Segmentation by therapeutic area Key for relevance; oncology contacts do not care about cardiovascular offerings

Segmentation

Axis Categories Why it matters
Company type Big Pharma, biotech, CRO, CDMO, device, generic Completely different buying processes
Therapeutic area Oncology, immunology, neuroscience, cardiovascular, rare diseases, etc. Determines relevance of offerings
Development stage Discovery, preclinical, Phase I-III, commercial Needs change dramatically by stage
Company size Under 50, 50-500, 500-5000, 5000+ employees Affects procurement process and budget
Geography US, EU, Japan, China, rest of world Regulatory environment and market access differ
Regulatory status FDA-approved products vs pre-approval Revenue stage and compliance requirements differ

Metrics for Pharma Outreach

Metric Typical range Notes
Open rate (cold) 25-40% Lower than some industries due to strict email filtering
Reply rate (cold) 2-5% Pharma decision makers are heavily targeted
Meeting booking rate 0.5-2% Long sales cycles; may require multiple touchpoints
Sales cycle length 3-18 months Longer for enterprise pharma; shorter for biotech
Best time to send 7:00-9:00 local time, Tuesday-Thursday Consistent with most B2B
Conference follow-up window Within 1 week of event Timeliness matters for conference contacts

Extract emails

Explore tools

Verify emails

Check address validity before using your list.

ZeroBounce

Email Verification

Verifies email lists and provides tools for monitoring deliverability.

Useful when list cleaning and sender health belong in one workflow.

Explore ZeroBounce (opens in a new tab)